# FDA Inspection 1012266 - Cangene BioPharma, LLC - March 22, 2017

Source: https://www.keypedia.com/records/fda_inspections/cangene-biopharma-llc/2dd7597d-ab49-4a1e-9cda-cdc92f96614e
Source feed: FDA_Inspections

> FDA Inspection 1012266 for Cangene BioPharma, LLC on March 22, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1012266
- Company Name: Cangene BioPharma, LLC
- Inspection Date: 2017-03-22
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1084658 - 2019-02-16](https://www.keypedia.com/records/fda_inspections/cangene-biopharma-llc/ee254e98-f217-41a7-a3d2-7d505cf22b5c)
- [FDA Inspection 928289 - 2015-04-17](https://www.keypedia.com/records/fda_inspections/cangene-biopharma-llc/24398975-20bd-4979-9e9b-af59510e7ad3)

Company: https://www.keypedia.com/companies/cangene-biopharma-llc/d685e3d6-8e3c-4950-b2f9-9b3aaea0df9d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d